Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice

• मुख्य लेखकों: Selma Atalay (लेखक), Lara S. van der Schoot (लेखक), Laura Vandermaesen (लेखक), Lieke J. van Vugt (लेखक), Mascha Eilander (लेखक), Juul M.P.A. van den Reek (लेखक), Elke M.G.J. de Jong (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Medical Journals Sweden, 2021-05-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Dose reduction of biologics for psoriasis could contribute to lower drug exposure. This study evaluated a one-step, tightly controlled, biologic dose reduction strategy in a prospective daily practice cohort. In patients with psoriasis with low disease activity using adalimumab, etanercept or usteki...